- Home
- HOUR vs IMUX Comparison
HOUR vs IMUX Comparison
Compare HOUR & IMUX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HOUR
- IMUX
- Stock Information
- Founded
- HOUR 2015
- IMUX 2016
- Country
- HOUR United States
- IMUX United States
- Employees
- HOUR N/A
- IMUX N/A
- Industry
- HOUR Catalog/Specialty Distribution
- IMUX Biotechnology: Pharmaceutical Preparations
- Sector
- HOUR Consumer Discretionary
- IMUX Health Care
- Exchange
- HOUR Nasdaq
- IMUX Nasdaq
- Market Cap
- HOUR 63.3M
- IMUX 67.8M
- IPO Year
- HOUR 2022
- IMUX N/A
- Fundamental
- Price
- HOUR $1.80
- IMUX $0.98
- Analyst Decision
- HOUR
- IMUX Strong Buy
- Analyst Count
- HOUR 0
- IMUX 5
- Target Price
- HOUR N/A
- IMUX $7.50
- AVG Volume (30 Days)
- HOUR 40.0K
- IMUX 1.0M
- Earning Date
- HOUR 08-15-2025
- IMUX 08-19-2025
- Dividend Yield
- HOUR N/A
- IMUX N/A
- EPS Growth
- HOUR N/A
- IMUX N/A
- EPS
- HOUR 0.01
- IMUX N/A
- Revenue
- HOUR $139,408,829.00
- IMUX N/A
- Revenue This Year
- HOUR N/A
- IMUX N/A
- Revenue Next Year
- HOUR N/A
- IMUX N/A
- P/E Ratio
- HOUR $248.36
- IMUX N/A
- Revenue Growth
- HOUR 2.71
- IMUX N/A
- 52 Week Low
- HOUR $0.83
- IMUX $0.56
- 52 Week High
- HOUR $6.90
- IMUX $2.11
- Technical
- Relative Strength Index (RSI)
- HOUR 59.60
- IMUX 56.90
- Support Level
- HOUR $1.66
- IMUX $0.89
- Resistance Level
- HOUR $1.89
- IMUX $1.01
- Average True Range (ATR)
- HOUR 0.10
- IMUX 0.08
- MACD
- HOUR -0.02
- IMUX -0.00
- Stochastic Oscillator
- HOUR 48.28
- IMUX 30.83
About HOUR Hour Loop Inc.
Hour Loop Inc is a technology-enabled consumer products company that uses machine learning and data analytics to design, develop, market, and sell products. Hour Loop predominantly operates through online retail channels such as Amazon, Walmart, and Hourloop.com. The Company, as an Internet marketplace seller, sells products in multiple categories, including home/garden decor, toys, kitchenware, apparel, and electronics. It has only one segment, which is online retail (e-commerce).
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.